Company Filing History:
4 out of 151 
1 out of 1,179 
1 out of 2,483 
Years Active: 2014-2022
Title: The Innovations of Michael Thiele
Introduction
Michael Thiele is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of immunohistochemistry, particularly in the detection of macrophage migration inhibitory factor (MIF). With a total of four patents to his name, Thiele's work has advanced the understanding and detection of specific antibodies in tissues.
Latest Patents
Thiele's latest patents include innovative methods for the specific detection of MIF, especially oxMIF, in tissues. One of his patents focuses on a detection method that utilizes immunohistochemistry, employing specific anti-oxMIF antibodies. Another patent also pertains to the detection of MIF and anti-oxMIF antibodies in tissues, using immunohistochemistry or immunofluorescence with specific idiotypic monoclonal rabbit antibodies.
Career Highlights
Throughout his career, Michael Thiele has worked with prominent companies in the pharmaceutical industry, including Baxalta GmbH and Takeda Pharmaceutical Company Limited. His expertise in immunology and antibody detection has positioned him as a valuable asset in these organizations.
Collaborations
Thiele has collaborated with several professionals in his field, including Randolf Kerschbaumer and Patrice Douillard. These collaborations have likely contributed to the success of his innovative projects and patents.
Conclusion
Michael Thiele's contributions to immunohistochemistry and his innovative patents demonstrate his commitment to advancing medical science. His work continues to impact the field positively, showcasing the importance of innovation in healthcare.